Targeting VEGF signaling and stromal remodeling enhances chemoimmunotherapy efficacy in esophageal cancer
{{output}}
Background: Neoadjuvant chemoimmunotherapy (NACI) has shown promising results in treating esophageal squamous cell carcinoma (ESCC), yet the mechanisms driving its efficacy remain poorly defined, limiting further optimization of ... ...
